SS
CLBT icon

SBI Securities’s Cellebrite CLBT Stock Holding History

SBI Securities’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$423 Buy
29
+6
+26% +$79 ﹤0.01% 3094
2026
Q1 		$317 Buy
23
+9
+64% +$136 ﹤0.01% 3058
2025
Q4 		$252 Sell
14
-130
-90% -$2.33K ﹤0.01% 3138
2025
Q3 		$2.67K Sell
144
-22
-13% -$346 ﹤0.01% 2316
2025
Q2 		$2.66K Buy
166
+153
+1,177% +$2.73K ﹤0.01% 2272
2025
Q1 		$253 Sell
13
-110
-89% -$2.31K ﹤0.01% 3137
2024
Q4 		$2.71K Buy
+123
New +$2.37K ﹤0.01% 2180

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

SBI Securities's CLBT Position: Q2 2026 in Review

SBI Securities increased its Cellebrite (CLBT) stake by 26% in Q2 2026, buying an estimated $79 and bringing the position to 29 shares worth $423. The position accounts for ﹤0.01% of the portfolio, ranked #3094.

SBI Securities first reported a position in CLBT in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.71K in Q4 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • SBI Securities held 29 shares of Cellebrite worth $423 as of Q2 2026.
  • SBI Securities bought 6 Cellebrite shares in Q2 2026, an estimated $79.
  • Cellebrite made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3094 holding.
  • SBI Securities first reported a position in Cellebrite in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Cellebrite position peaked at $2.71K in Q4 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.